Clinical Trial Update: Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients. [NA]

View source ↗

Summary

A completed clinical trial evaluating the effectiveness of oral alfacalcidol for secondary hyperparathyroidism in patients on chronic hemodialysis. Sponsor: Phr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism

Drugs mentioned

• Alfacalcidol (alfacalcidol)

Snippet

Sponsor: Phramongkutklao College of Medicine and Hospital | Conditions: Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis | NA | Status: COMPLETED